Skip to main content

Table 1 Patients general characteristics and indication for sedation

From: Midazolam sedation in palliative medicine: retrospective study in a French center for cancer control

Characteristics (N = 54)

n

%

Age (years)

 Median (range)

56.9

(25.6–85.7)

 Mean (standard deviation)

56.9

(13.1)

Gender

 Female

31

57.4%

 Male

23

42.6%

Medical supervision unit

 Palliative care

17

31.5%

 Uro-digestive

12

22.2%

 Breast

10

18.5%

 General Oncology

8

14.8%

 Upper aerodigestive tract

5

9.3%

 Gynecology

2

3.7%

Primitive Tumor

 Breast

11

20.4%

 Upper aerodigestive tract

10

18.5%

 Lung

6

11.1%

 Colon-rectum

4

7.4%

 Œsophagus

4

7.4%

 Soft tissue sarcoma

4

7.4%

 Cervix

2

3.7%

 Prostate

2

3.7%

 Bladder

2

3.7%

 Anal canal

1

1.9%

 Lymphoma

1

1.9%

 Bone

1

1.9%

 Ovary

1

1.9%

 Skin

1

1.9%

 Kidney

1

1.9%

 Biliary

1

1.9%

 Unknown

2

3.7%

Indication for sedation

 Immediate risk of death

25

46.3%

Respiratory distress

18

33.3%

Hemorrhage

5

9.3%

Hemodynamic shock

2

3.7%

 Refractory symptoms a

26

48.1%

Respiratory disorders

10

18.5%

Agitation and confusion

9

16.7%

Anxiety

4

7.4%

Pain

2

3.7%

Bleeding

1

1.9%

Asthenia

1

1.9%

Status epilepticus

1

1.9%

Existential suffering

3

5.6%

  1. a Some patients had several symptoms